Derivative Liabilities (Details) - Schedule of warrant activity |
12 Months Ended |
---|---|
Dec. 31, 2020
USD ($)
$ / shares
shares
| |
Schedule of warrant activity [Abstract] | |
Number of Warrants outstanding beginning | shares | |
Weighted Average Exercise Price outstanding beginning | $ / shares | |
Number of Warrants Issued | shares | 6,064,908 |
Weighted Average Exercise Price Issued | $ / shares | $ 11.43 |
Number of Warrants outstanding ending | shares | 6,064,908 |
Weighted Average Exercise Price outstanding ending | $ / shares | $ 11.43 |
Weighted Average Remaining Life In Years outstanding ending | 4 years 328 days |
Aggregate Intrinsic Value outstanding ending | $ | |
Number of Warrants Exercisable | shares | 6,001,250 |
Weighted Average Exercise Price Exercisable | $ / shares | $ 11.50 |
Weighted Average Remaining Life In Years Exercisable | 4 years 328 days |
Aggregate Intrinsic Value Exercisable | $ |
X | ||||||||||
- Definition Number of outstanding warrants. No definition available.
|
X | ||||||||||
- Definition Number of warrants exercisable shares. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Gross number of share warrants (or share units) granted during the period. No definition available.
|
X | ||||||||||
- Definition Weighted average remaining contractual term of outstanding stock options. No definition available.
|
X | ||||||||||
- Definition Weighted Average Exercise Price Issued. No definition available.
|
X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|